Search Results 131-140 of 17216 for hba1c

  1. A Study Of The Effects Of Inflammation On Fat Tissue And Insulin In People With Different Body Shapes - Mayo Clinic

    For Type II Diabetic volunteers they will need a HbA1C between 7.0% and 9.5%. As with obese participants (above), transaminase, glucose and lipid values are ...

  2. A Study Of The Clinical Experience And Acceptance Of The Artificial Pancreas

    HbA1c level <10.5% at screening; For females, not currently known to be pregnant. If female and sexually active, must agree to use a form of contraception to ...

  3. Shared Decision Making With Pharmaceutical Care - Mayo Clinic

    HbA1c of 7%-9.5% within past 6 months; Prescribed three or less anti-hyperglycemic medications as indicated by the medication list within the medical record.

  4. Mediterranean Diet Post-liver Transplantation - Mayo Clinic

    - Uncontrolled diabetes mellitus (HbA1c > 10%) - Associated medical conditions incompatible with safe participation in a nutritional intervention study ...

  5. Study of TERN-601 in Adults with Overweight or Obesity - Mayo Clinic

    HbA1c ≥ 6.5% (48 mmol/mol),; Fasting glucose ≥ 126 mg/dL (7.0 mmol/L), or; Random glucose ≥ 200 mg/dL (11.1 mmol/L). Have had or are planning surgical ...

  6. Research Study To Look At How Well Semaglutide Works In People Living With Heart Failure, Obesity And Type 2 Diabetes - Mayo Clinic

    HbA1c of below or equal to 10.0% as measured at the screening visit. Exclusion Criteria: A self-reported change in body weight greater than 5 kg (11 lbs) ...

  7. A Study to Compare Model Predictive Control (MPC) Artificial Pancreas vs. Sensor Augmented Pump (SAP)/Predictive Low Glucose Suspend (PLGS) with Different Stress Assessments for Type 1 Diabetes Patients - Mayo Clinic

    HbA1c < 10.5%, as performed by point of care or central 513 laboratory testing. A1c will be 514 assessed at the screening visit, or if already completed ...

  8. Safety And Efficacy Of Selonsertib, GS-0976, GS-9674, And Combinations In Participants With Bridging Fibrosis Or Compensated Cirrhosis Due To Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    HbA1c ≤ 9.5%; Alanine aminotransferase (ALT) < 5 x Upper Limits of Normal (ULN); Platelet count ≥ 125,000/μL. Exclusion Criteria: Prior history of ...

  9. https://www.mayoclinic.org/spanish_procedure_concepts.xml

  10. Assess Glycemic Improvements in People with Type 2 Diabetes Using a Novel Hybrid Closed Loop Insulin Pump - Mayo Clinic

    Presence of a hemoglobinopathy or other condition that is expected to affect the measurement of HbA1c in the judgment of the investigator. Immediate family ...